Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AMTM - US0239391016 - Common Stock

31.36 USD
+5.99 (+23.61%)
Last: 11/25/2025, 10:22:08 AM
Fundamental Rating

2

Taking everything into account, AMTM scores 2 out of 10 in our fundamental rating. AMTM was compared to 87 industry peers in the Professional Services industry. AMTM has a bad profitability rating. Also its financial health evaluation is rather negative. AMTM has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AMTM was profitable.
AMTM had a positive operating cash flow in the past year.
In the past 5 years AMTM reported 4 times negative net income.
Of the past 5 years AMTM 4 years had a positive operating cash flow.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

With a Return On Assets value of 0.44%, AMTM perfoms like the industry average, outperforming 42.53% of the companies in the same industry.
The Return On Equity of AMTM (1.17%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.48%, AMTM is in line with its industry, outperforming 41.38% of the companies in the same industry.
AMTM had an Average Return On Invested Capital over the past 3 years of 2.31%. This is significantly below the industry average of 12.15%.
The 3 year average ROIC (2.31%) for AMTM is below the current ROIC(2.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROIC 2.48%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

AMTM has a Profit Margin of 0.41%. This is comparable to the rest of the industry: AMTM outperforms 43.68% of its industry peers.
AMTM's Operating Margin of 2.39% is in line compared to the rest of the industry. AMTM outperforms 44.83% of its industry peers.
AMTM's Operating Margin has been stable in the last couple of years.
AMTM has a worse Gross Margin (10.21%) than 86.21% of its industry peers.
AMTM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMTM is destroying value.
AMTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

AMTM has an Altman-Z score of 1.73. This is a bad value and indicates that AMTM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AMTM (1.73) is worse than 63.22% of its industry peers.
The Debt to FCF ratio of AMTM is 32.53, which is on the high side as it means it would take AMTM, 32.53 years of fcf income to pay off all of its debts.
AMTM has a worse Debt to FCF ratio (32.53) than 62.07% of its industry peers.
AMTM has a Debt/Equity ratio of 1.00. This is a neutral value indicating AMTM is somewhat dependend on debt financing.
The Debt to Equity ratio of AMTM (1.00) is worse than 70.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Altman-Z 1.73
ROIC/WACC0.31
WACC8.13%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.58 indicates that AMTM should not have too much problems paying its short term obligations.
AMTM has a Current ratio (1.58) which is comparable to the rest of the industry.
AMTM has a Quick Ratio of 1.58. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.58, AMTM is in line with its industry, outperforming 57.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.1%

3.2 Future

Based on estimates for the next years, AMTM will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.08% on average per year.
The Revenue is expected to grow by 3.21% on average over the next years.
EPS Next Y9.55%
EPS Next 2Y11.16%
EPS Next 3Y12.95%
EPS Next 5Y12.08%
Revenue Next Year0.08%
Revenue Next 2Y1.84%
Revenue Next 3Y2.91%
Revenue Next 5Y3.21%

3.3 Evolution

AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.06, which indicates a correct valuation of AMTM.
Based on the Price/Earnings ratio, AMTM is valued cheaper than 81.61% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.65, AMTM is valued a bit cheaper.
The Price/Forward Earnings ratio is 12.84, which indicates a correct valuation of AMTM.
Based on the Price/Forward Earnings ratio, AMTM is valued cheaply inside the industry as 81.61% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.45, AMTM is valued rather cheaply.
Industry RankSector Rank
PE 14.06
Fwd PE 12.84
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

64.37% of the companies in the same industry are more expensive than AMTM, based on the Enterprise Value to EBITDA ratio.
AMTM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 55.37
EV/EBITDA 13.19
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as AMTM's earnings are expected to grow with 12.95% in the coming years.
PEG (NY)1.47
PEG (5Y)N/A
EPS Next 2Y11.16%
EPS Next 3Y12.95%

0

5. Dividend

5.1 Amount

No dividends for AMTM!.
Industry RankSector Rank
Dividend Yield N/A

AMENTUM HOLDINGS INC

NYSE:AMTM (11/25/2025, 10:22:08 AM)

31.36

+5.99 (+23.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-24 2025-11-24/amc
Earnings (Next)N/A N/A
Inst Owners66.11%
Inst Owner Change0.3%
Ins Owners0.56%
Ins Owner Change35.3%
Market Cap7.63B
Revenue(TTM)N/A
Net Income(TTM)52.20M
Analysts75
Price Target29.07 (-7.3%)
Short Float %6.42%
Short Ratio6.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)2.91%
Max EPS beat(2)10.16%
EPS beat(4)4
Avg EPS beat(4)26.92%
Min EPS beat(4)2.91%
Max EPS beat(4)84.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)-0.23%
Revenue beat(4)2
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)2.38%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.98%
PT rev (3m)5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.44%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)-0.32%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 14.06
Fwd PE 12.84
P/S 0.6
P/FCF 55.37
P/OCF 47.69
P/B 1.71
P/tB N/A
EV/EBITDA 13.19
EPS(TTM)2.23
EY7.11%
EPS(NY)2.44
Fwd EY7.79%
FCF(TTM)0.57
FCFY1.81%
OCF(TTM)0.66
OCFY2.1%
SpS52.11
BVpS18.32
TBVpS-13.29
PEG (NY)1.47
PEG (5Y)N/A
Graham Number30.32
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROCE 3.14%
ROIC 2.48%
ROICexc 2.69%
ROICexgc 19.81%
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
FCFM 1.09%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Debt/EBITDA 5.91
Cap/Depr 4.94%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 21.28%
Profit Quality 264.03%
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.73
F-Score6
WACC8.13%
ROIC/WACC0.31
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.04%
EPS Next Y9.55%
EPS Next 2Y11.16%
EPS Next 3Y12.95%
EPS Next 5Y12.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.1%
Revenue Next Year0.08%
Revenue Next 2Y1.84%
Revenue Next 3Y2.91%
Revenue Next 5Y3.21%
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year106.7%
EBIT Next 3Y31.25%
EBIT Next 5Y21.16%
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A

AMENTUM HOLDINGS INC / AMTM FAQ

What is the ChartMill fundamental rating of AMENTUM HOLDINGS INC (AMTM) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AMTM.


What is the valuation status of AMENTUM HOLDINGS INC (AMTM) stock?

ChartMill assigns a valuation rating of 7 / 10 to AMENTUM HOLDINGS INC (AMTM). This can be considered as Undervalued.


Can you provide the profitability details for AMENTUM HOLDINGS INC?

AMENTUM HOLDINGS INC (AMTM) has a profitability rating of 3 / 10.


What is the financial health of AMENTUM HOLDINGS INC (AMTM) stock?

The financial health rating of AMENTUM HOLDINGS INC (AMTM) is 2 / 10.


What is the expected EPS growth for AMENTUM HOLDINGS INC (AMTM) stock?

The Earnings per Share (EPS) of AMENTUM HOLDINGS INC (AMTM) is expected to grow by 9.55% in the next year.